Compound Summary
Compound Information
felbinac
Compound Name: | felbinac |
Compound CID: | 3332 |
Synonyms: | felbinac 4-BIPHENYLACETIC ACID 5728-52-9 4-Biphenylylacetic acid Traxam More... |
Iupac Name: | 2-(4-phenylphenyl)acetic acid |
InChI: | InChI=1S/C14H12O2/c15-14(16)10-11-6-8-13(9-7-11)12-4-2-1-3-5-12/h1-9H,10H2,(H,15,16) |
InChIKey: | QRZAKQDHEVVFRX-UHFFFAOYSA-N |
Canonical Smiles: | C1=CC=C(C=C1)C2=CC=C(C=C2)CC(=O)O |
Isomeric Smiles: | C1=CC=C(C=C1)C2=CC=C(C=C2)CC(=O)O |
Molecular Weight: | 212.24 |
Molecular Formula: | C14H12O2 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
felbinac
Molecular Weight: | 212.24 |
Molecular Formula: | C14H12O2 |
Hydrogen Bond Donor Count: | 1 |
Hydrogen Bond Acceptor Count: | 2 |
Rotatable Bond Count: | 3 |
Heavy Atom Count: | 16 |
Complexity: | 223 |
Synonyms
felbinac
| felbinac | felbinac |
|---|---|
felbinac |
4-BIPHENYLACETIC ACID |
5728-52-9 |
4-Biphenylylacetic acid |
Traxam |
Dolinac |
biphenyl-4-ylacetic acid |
Napageln |
2-(4-phenylphenyl)acetic acid |
4-Carboxymethylbiphenyl |
p-Biphenylylacetic acid |
1,1-Biphenyl-4-acetic acid |
p-Biphenylacetic acid |
Seltouch |
Biphenyl-4-acetic acid |
LJC 10,141 |
Biphenyl-4-yl-acetic acid |
4-Biphenylaceticacid |
Acetic acid, (4-biphenylyl)- |
CL 83544 |
LY 61017 |
(1,1-Biphenyl)-4-acetic acid |
L-141 |
NSC 16284 |
2-(biphenyl-4-yl)acetic acid |
2-(1,1-biphenyl-4-yl)acetic acid |
4-biphenyl acetic acid |
LJC-10141 |
NSC-16284 |
CL-83544 |
CL 83,544 |
MLS000069466 |
94WNJ5U8L7 |
CHEBI:31597 |
1,1-Biphenyl-4-ylacetic acid |
Ly-61017 |
NCGC00016660-01 |
SMR000059071 |
CAS-5728-52-9 |
Felbinacum Latin |
Felbinaco Spanish |
Felbinacum |
Felbinaco |
2-{1,1-biphenyl-4-yl}acetic acid |
Felbinac USAN:INN:BAN:JAN |
EINECS 227-233-2 |
MFCD00004351 |
BRN 1211592 |
UNII-94WNJ5U8L7 |
Dolonac |
Flexfree |
Ledergel |
Napagel |
Selspot |
Sumilu |
L 141 |
Zenol EXUM |
Felbinac (TN) |
BP4 |
Dolinac (TN) |
BPAA |
EMEC |
biphenyl-4acetic acid |
4-biphenyl-acetic acid |
FELBINAC USAN |
Opera_ID_534 |
FELBINAC INN |
FELBINAC JAN |
FELBINAC MI |
4-biphenylyl acetic acid |
4-phenylphenylacetic acid |
Prestwick0_000893 |
Prestwick1_000893 |
Prestwick2_000893 |
Prestwick3_000893 |
(4-biphenyl)acetic acid |
FELBINAC WHO-DD |
(Biphenyl-4-yl)acetic aci |
(Biphenyl-4-yl)acetic acid |
Oprea1_058748 |
SCHEMBL26084 |
BSPBio_000706 |
4-Biphenylacetic acid, 98% |
SPBio_002915 |
4-l,lbiphenylylacetic acid |
BPBio1_000778 |
CHEMBL413965 |
Felbinac (JP17/USAN/INN) |
ZINC2318 |
FELBINAC EP MONOGRAPH |
DTXSID0045389 |
1,1-biphenyl-4-ylacetic acid |
HFN-310 |
BDBM223312 |
HMS1570D08 |
HMS2097D08 |
HMS3714D08 |
Pharmakon1600-01506160 |
BCP18699 |
CS-D1194 |
HY-B0641 |
NSC16284 |
Tox21_110549 |
AR1730 |
NSC760372 |
s3685 |
STK387569 |
AKOS000119696 |
Tox21_110549_1 |
1,1-Biphenyl-4-ylacetic acid # |
AC-8104 |
AS-2883 |
CCG-213621 |
CS-8026 |
DB07477 |
NSC-760372 |
NCGC00016660-02 |
NCGC00016660-03 |
NCGC00016660-04 |
NCGC00016660-06 |
DB-022648 |
AB00384278 |
B1278 |
FT-0602170 |
FT-0617678 |
EN300-20102 |
28B529 |
B-2700 |
D01675 |
AB00384278_14 |
SR-01000003008 |
Q3742067 |
SR-01000003008-2 |
BRD-K91740057-001-16-4 |
F2191-0076 |
Felbinac, European Pharmacopoeia (EP) Reference Standard |
Z104476858 |
Experimental Data
felbinac
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 50 | umol/L | 10.49 | S | N2 | 30970250 | Active | ||||||
| Caenorhabditis elegans | 50 | umol/L | 50.36 | S | N2 | 30970250 | Active |
Experimental Data Visualization
felbinac
Statistics Data
felbinac
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 50.36 | 1 | 2 |
Statistics Data Visualization
felbinac
